|
1
|
Varambally S, Dhanasekaran SM, Zhou M,
Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt
RG, Otte AP, et al: The polycomb group protein EZH2 is involved in
progression of prostate cancer. Nature. 419:624–629. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tsai HT, Penson DF, Makambi KH, Lynch JH,
Van Den Eeden SK and Potosky AL: Efficacy of intermittent androgen
deprivation therapy vs conventional continuous androgen deprivation
therapy for advanced prostate cancer: A meta-analysis. Urology.
82:327–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Suzuki Y, Demoliere C, Kitamura D,
Takeshita H, Deuschle U and Watanabe T: HAX-1, a novel
intracellular protein, localized on mitochondria, directly
associates with HS1, a substrate of Src family tyrosine kinases. J
Immunol. 158:2736–2744. 1997.PubMed/NCBI
|
|
4
|
Mirmohammadsadegh A, Tartler U, Michel G,
Baer A, Walz M, Wolf R, Ruzicka T and Hengge UR: HAX-1, identified
by differential display reverse transcription polymerase chain
reaction, is overexpressed in lesional psoriasis. J Invest
Dermatol. 120:1045–1051. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sharp TV, Wang H-W, Koumi A, Hollyman D,
Endo Y, Ye H, Du MQ and Boshoff C: K15 protein of Kaposi's
sarcoma-associated herpesvirus is latently expressed and binds to
HAX-1, a protein with antiapoptotic function. J Virol. 76:802–816.
2002. View Article : Google Scholar
|
|
6
|
Trebinska A, Rembiszewska A, Ciosek K,
Ptaszynski K, Rowinski S, Kupryjanczyk J, Siedlecki JA and
Grzybowska EA: HAX-1 overexpression, splicing and cellular
localization in tumors. BMC Cancer. 10:762010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jing YY, Li XL, Shi Q, Wang ZY, Guo Y, Pan
MM, Tian C, Zhu SY, Chen C, Gong HS, et al: A novel PrP partner
HS-1 associated protein X-1 (HAX-1) protected the cultured cells
against the challenge of H2O2. J Mol
Neurosci. 45:216–228. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wei XJ, Li SY, Yu B, Chen G, Du JF and Cai
HY: Expression of HAX-1 in human colorectal cancer and its clinical
significance. Tumour Biol. 35:1411–1415. 2014. View Article : Google Scholar
|
|
9
|
Shaw J and Kirshenbaum LA: HAX-1 represses
post-mitochondrial caspase-9 activation and cell death during
hypoxia-reoxygenation. Circ Res. 99:336–338. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mahdavi M, Davoodi J, Zali MR and
Foroumadi A: Concomitant activation of caspase-9 and
down-regulation of IAP proteins as a mechanism of apoptotic death
in HepG2, T47D and HCT-116 cells upon exposure to a derivative from
4-aryl-4H-chromenes family. Biomed Pharmacother. 65:175–182. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Han Y, Chen YS, Liu Z, Bodyak N, Rigor D,
Bisping E, Pu WT and Kang PM: Overexpression of HAX-1 protects
cardiac myocytes from apoptosis through caspase-9 inhibition. Circ
Res. 99:415–423. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Elstner E, Müller C, Koshizuka K,
Williamson EA, Park D, Asou H, Shintaku P, Said JW, Heber D and
Koeffer HP: Ligands for peroxisome proliferator-activated
receptorgamma and retinoic acid receptor inhibit growth and induce
apoptosis of human breast cancer cells in vitro and in BNX mice.
Proc Natl Acad Sci USA. 95:8806–8811. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hsieh TC and Wu JM: Differential effects
on growth, cell cycle arrest, and induction of apoptosis by
resveratrol in human prostate cancer cell lines. Exp Cell Res.
249:109–115. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hsu AL, Ching TT, Wang DS, Song X,
Rangnekar VM and Chen CS: The cyclooxygenase-2 inhibitor celecoxib
induces apoptosis by blocking Akt activation in human prostate
cancer cells independently of Bcl-2. J Biol Chem. 275:11397–11403.
2000. View Article : Google Scholar
|
|
15
|
Fulda S: Evasion of apoptosis as a
cellular stress response in cancer. Int J Cell Biol.
2010:3708352010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Plati J, Bucur O and Khosravi-Far R:
Apoptotic cell signaling in cancer progression and therapy. Integr
Biol Camb. 3:279–296. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Akgul C: Mcl-1 is a potential therapeutic
target in multiple types of cancer. Cell Mol Life Sci.
66:1326–1336. 2009. View Article : Google Scholar
|
|
18
|
Vidya Priyadarsini R, Senthil Murugan R,
Maitreyi S, Ramalingam K, Karunagaran D and Nagini S: The flavonoid
quercetin induces cell cycle arrest and mitochondria-mediated
apoptosis in human cervical cancer (HeLa) cells through p53
induction and NF-κB inhibition. Eur J Pharmacol. 649:84–91. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li WB, Feng J, Geng SM, Zhang PY, Yan XN,
Hu G, Zhang CQ and Shi BJ: Induction of apoptosis by Hax-1 siRNA in
melanoma cells. Cell Biol Int. 33:548–554. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yap SV, Koontz JM and
Kontrogianni-Konstantopoulos A: HAX-1: A family of apoptotic
regulators in health and disease. J Cell Physiol. 226:2752–2761.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li M, Tang Y, Zang W, Xuan X, Wang N, Ma
Y, Wang Y, Dong Z and Zhao G: Analysis of HAX-1 gene expression in
esophageal squamous cell carcinoma. Diagn Pathol. 8:472013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ferri KF and Kroemer G: Organelle-specific
initiation of cell death pathways. Nat Cell Biol. 3:E255–E263.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Philchenkov A: Caspases: Potential targets
for regulating cell death. J Cell Mol Med. 8:432–444. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yin C, Knudson CM, Korsmeyer SJ and Van
Dyke T: Bax suppresses tumorigenesis and stimulates apoptosis in
vivo. Nature. 385:637–640. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Youle RJ and Strasser A: The BCL-2 protein
family: Opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. PubMed/NCBI
|
|
26
|
Zong WX, Li C, Hatzivassiliou G, Lindsten
T, Yu QC, Yuan J and Thompson CB: Bax and Bak can localize to the
endoplasmic reticulum to initiate apoptosis. J Cell Biol.
162:59–69. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deveraux QL and Reed JC: IAP family
proteins - suppressors of apoptosis. Genes Dev. 13:239–252. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fadeel B and Grzybowska E: HAX-1: A
multifunctional protein with emerging roles in human disease.
Biochim Biophys Acta. 1790:1139–1148. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cilenti L, Soundarapandian MM, Kyriazis
GA, Stratico V, Singh S, Gupta S, Bonventre JV, Alnemri ES and
Zervos AS: Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2
protease during cell death. J Biol Chem. 279:50295–50301. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gupta K, Thakur VS, Bhaskaran N, Nawab A,
Babcook MA, Jackson MW and Gupta S: Green tea polyphenols induce
p53-dependent and p53-independent apoptosis in prostate cancer
cells through two distinct mechanisms. PLoS One. 7:e525722012.
View Article : Google Scholar
|
|
31
|
Martinou JC and Youle RJ: Mitochondria in
apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev
Cell. 21:92–101. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brentnall M, Rodriguez-Menocal L, De
Guevara RL, Cepero E and Boise LH: Caspase-9, caspase-3 and
caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell
Biol. 14:322013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li P, Nijhawan D, Budihardjo I,
Srinivasula SM, Ahmad M, Alnemri ES and Wang X: Cytochrome c and
dATP-dependent formation of Apaf-1/caspase-9 complex initiates an
apoptotic protease cascade. Cell. 91:479–489. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Srinivasula SM, Ahmad M, Fernandes-Alnemri
T and Alnemri ES: Autoactivation of procaspase-9 by Apaf-1-mediated
oligomerization. Mol Cell. 1:949–957. 1998. View Article : Google Scholar : PubMed/NCBI
|
